289 related articles for article (PubMed ID: 35727133)
21. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
[TBL] [Abstract][Full Text] [Related]
23. A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.
Yin H; Karayel O; Chao YY; Seeholzer T; Hamp I; Plettenburg O; Gehring T; Zielinski C; Mann M; Krappmann D
Cell Mol Life Sci; 2022 Jan; 79(2):112. PubMed ID: 35099607
[TBL] [Abstract][Full Text] [Related]
24. From MALT lymphoma to the CBM signalosome: three decades of discovery.
Rosebeck S; Rehman AO; Lucas PC; McAllister-Lucas LM
Cell Cycle; 2011 Aug; 10(15):2485-96. PubMed ID: 21750409
[TBL] [Abstract][Full Text] [Related]
25. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
26. MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.
Gehring T; Erdmann T; Rahm M; Graß C; Flatley A; O'Neill TJ; Woods S; Meininger I; Karayel O; Kutzner K; Grau M; Shinohara H; Lammens K; Feederle R; Hauck SM; Lenz G; Krappmann D
Cell Rep; 2019 Oct; 29(4):873-888.e10. PubMed ID: 31644910
[TBL] [Abstract][Full Text] [Related]
27. Study of individual domains contributing to MALT1 dimerization in BCL10-independent and dependent assembly.
Kuo BJ; Lin SC; Tu YF; Huang PH; Lo YC
Biochem Biophys Res Commun; 2024 Jul; 717():150029. PubMed ID: 38714015
[TBL] [Abstract][Full Text] [Related]
28. Regulation mechanisms of CARMA1-Bcl10-MALT1 complex assembly inferred from the analysis of TRAF6-deficient cells.
Inoue K; Yasuda T; Baba Y; Yamamoto T; Kurosaki T; Shinohara H
Genes Cells; 2023 Jun; 28(6):411-421. PubMed ID: 36871192
[TBL] [Abstract][Full Text] [Related]
29. BCL10 - Bridging CARDs to Immune Activation.
Gehring T; Seeholzer T; Krappmann D
Front Immunol; 2018; 9():1539. PubMed ID: 30022982
[TBL] [Abstract][Full Text] [Related]
30. Picomolar zinc binding modulates formation of Bcl10-nucleating assemblies of the caspase recruitment domain (CARD) of CARD9.
Holliday MJ; Ferrao R; de Leon Boenig G; Estevez A; Helgason E; Rohou A; Dueber EC; Fairbrother WJ
J Biol Chem; 2018 Oct; 293(43):16803-16817. PubMed ID: 30206119
[TBL] [Abstract][Full Text] [Related]
31. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
McCully RR; Pomerantz JL
Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
Lork M; Staal J; Beyaert R
Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
[TBL] [Abstract][Full Text] [Related]
33. Multiple protein domains mediate interaction between Bcl10 and MALT1.
Langel FD; Jain NA; Rossman JS; Kingeter LM; Kashyap AK; Schaefer BC
J Biol Chem; 2008 Nov; 283(47):32419-31. PubMed ID: 18806265
[TBL] [Abstract][Full Text] [Related]
34. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
[TBL] [Abstract][Full Text] [Related]
35. Bcl10 phosphorylation-dependent droplet-like condensation positively regulates DNA virus-induced innate immune signaling.
Yang D; Pei G; Dong S; Zhang W; Deng H; Zhao X; Li P; Lin X
Sci China Life Sci; 2023 Feb; 66(2):283-297. PubMed ID: 36115893
[TBL] [Abstract][Full Text] [Related]
36. Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.
Moreno-García ME; Sommer K; Rincon-Arano H; Brault M; Ninomiya-Tsuji J; Matesic LE; Rawlings DJ
Mol Cell Biol; 2013 Mar; 33(6):1149-63. PubMed ID: 23297344
[TBL] [Abstract][Full Text] [Related]
37. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.
Bidère N; Ngo VN; Lee J; Collins C; Zheng L; Wan F; Davis RE; Lenz G; Anderson DE; Arnoult D; Vazquez A; Sakai K; Zhang J; Meng Z; Veenstra TD; Staudt LM; Lenardo MJ
Nature; 2009 Mar; 458(7234):92-6. PubMed ID: 19118383
[TBL] [Abstract][Full Text] [Related]
38. The CBM signalosome: potential therapeutic target for aggressive lymphoma?
Yang C; David L; Qiao Q; Damko E; Wu H
Cytokine Growth Factor Rev; 2014 Apr; 25(2):175-83. PubMed ID: 24411492
[TBL] [Abstract][Full Text] [Related]
39. Structural insights into the assembly of CARMA1 and BCL10.
Li S; Yang X; Shao J; Shen Y
PLoS One; 2012; 7(8):e42775. PubMed ID: 22880103
[TBL] [Abstract][Full Text] [Related]
40. CARD-BCL-10-MALT1 signalling in protective and pathological immunity.
Ruland J; Hartjes L
Nat Rev Immunol; 2019 Feb; 19(2):118-134. PubMed ID: 30467369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]